title: Exploratory use of docetaxel loaded acid-prepared mesoporous spheres for the treatment of malignant melanoma.
abstract: BACKGROUND
  Five year survival for metastatic melanoma (MM) is very low at <10%. Therapeutic options have been limited secondary to systemic toxicity. As a result there has been a growing movement towards developing targeted drug delivery models. Prior research of this group has demonstrated the effectiveness of acid-prepared mesoporous spheres (APMS-TEG) in delivering chemotherapeutic agents at a lower effective dose than systemic administration. This study aims to assess the ability of the previously developed APMS-TEG particles to deliver therapeutic doses of docetaxel for the treatment of melanoma.
  
  
  METHODS
  In vitroexperiments were performed to assess docetaxel loading onto APMS-TEG particles and release kinetics. Toxicity experiments were performed using docetaxel and docetaxel loaded APMS-TEG. The effect on cell growth was assessed using the MelJuSo, UACC903, and WM1205 melanoma cell lines.
  
  
  RESULTS
  Docetaxel demonstrated statistically significant dose dependent reduction in growth of melanoma cells. In all three cell lines, doses of 1 nM were sufficient to produce statistically significant reduction in cell growth. Scanning electron micrographs demonstrate increased uptake of APMS-TEG particles by melanoma cells in the first 24 hours, with the majority within the first 4 hours. Unloaded APMS particles had no effect on the melanoma cells, demonstrating that the particles themselves are not toxic. APMS-TEG particles had a peak release of drug within the first hour, with equilibration thereafter. The 5, 10, and 20 nM loaded particles all had statistically significant reduction in cell growth than the control groups.
  
  
  CONCLUSIONS
  The high potency against melanoma cells makes docetaxel a suitable choice for loading into APMS-TEG particles. Docetaxel loaded APMS-TEG particles demonstrate significant activity against malignant melanoma and thus offer an innovative approach to the treatment of metastatic melanoma.
authors: Department of Surgery, Danbury Hospital, Danbury, CT USA.
authors: Sameer
authors: S
authors: Kaiser
authors: Department of Pathology, University of Vermont, Burlington, VT USA.
authors: Maximilian B
authors: MB
authors: MacPherson
authors: Division of Surgical Oncology, Department of Surgery, University of Vermont, 89 Beaumont Ave, Burlington, VT 05405 USA.
authors: Ted A
authors: TA
authors: James
authors: University of Vermont College of Medicine, Burlington, VT USA.
authors: Albert
authors: A
authors: Emery
authors: Department of Pathology, University of Vermont, Burlington, VT USA.
authors: Page
authors: P
authors: Spiess
authors: Department of Pathology, University of Vermont, Burlington, VT USA.
authors: Albert
authors: A
authors: van der Vliet
authors: Department of Chemistry, University of Vermont, Burlington, VT USA.
authors: Christopher C
authors: CC
authors: Landry
authors: Department of Pathology, University of Vermont, Burlington, VT USA.
authors: Arti
authors: A
authors: Shukla
keywords: Docetaxel; Melanoma; Mesoporous; Microsphere; Nanoparticle; Silica
references: Int J Nanomedicine. 2012;7:3389-98
references: 22848167
references: Rev Environ Contam Toxicol. 2012;215:39-121
references: 22057930
references: Int J Cancer. 2011 Jul 1;129(1):233-44
references: 20830711
references: Cancer Chemother Pharmacol. 2011 Oct;68(4):1081-7
references: 21769667
references: Am J Respir Cell Mol Biol. 2007 Mar;36(3):333-42
references: 17038662
references: Clin Adv Hematol Oncol. 2007 May;5(5):386-94
references: 17673894
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: J Am Acad Dermatol. 2008 Dec;59(6):1081-5
references: 19022107
references: Adv Drug Deliv Rev. 2010 Mar 8;62(3):362-74
references: 19900497
references: N Engl J Med. 2011 Jun 30;364(26):2507-16
references: 21639808
references: BMC Clin Pharmacol. 2006 Jan 13;6:2
references: 16412237
references: Acta Biochim Biophys Sin (Shanghai). 2009 Jul;41(7):578-87
references: 19578721
references: Int J Hyg Environ Health. 2011 Jun;214(3):231-8
references: 21168363
references: Melanoma Res. 2010 Feb;20(1):43-7
references: 19952963